echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Reding Pharmaceuticals won the "2019 Pudong New Area high-growth enterprises outstanding contribution to the top 20"

    Reding Pharmaceuticals won the "2019 Pudong New Area high-growth enterprises outstanding contribution to the top 20"

    • Last Update: 2020-12-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On December 8th, the "2019 Pudong New Area Economic Outstanding Contribution Enterprise Recognition Event" hosted by the People's Government of Pudong New Area of Shanghai was held in Shanghai, and Ding Pharmaceuticals was awarded the "Top 20 Outstanding Contributions of High-Growth Enterprises in Pudong New Area in 2019".
    Yu Shuizhong, Chief Operating Officer of Reding Pharmaceutical Research and Development, attended the recognition event and received an honorary certificate from the leadership of the new district.
    Biopharmaceuticals is one of the six major 100 billion-scale hard-core industries in Pudong New Area, as an outstanding representative of Pudong Biopharmaceutical Industry, and then Ding Pharmaceuticals makes full use of its unique industry-first position, seizes great opportunities in the rapidly rising Chinese market, and strives to build the world's leading biopharmaceutical companies, which has played a positive role in the construction of the Pudong New Area free trade zone and science and technology center.
    6 years since its establishment, Weding has benefited from Pudong's high-quality entrepreneurial and innovative environment, relying on Pudong's policies, talents, resources and other advantages, rapid growth and growth.
    At present, Reding Pharmaceuticals continues to expand the industrial scale and global layout, there are currently 2 products in the commercial stage, 16 products and drug candidates, 30 ongoing and planned clinical research, nearly a thousand employees, set up a strong drug research and development and transformation research capabilities of the internal team, and gradually build a drug candidate pipeline with international intellectual property rights, step by step to grow into a fully integrated biopharmaceutical company.
    About Reding Pharmaceuticals (NASDAQ: ZLAB; Hong Kong Stock Exchange: 9688) is an innovative biopharmaceutical company in the commercial phase dedicated to providing innovative drugs to patients with cancer, autoimmune and infectious diseases in China and around the world.
    we are committed to meeting the enormous unseeded medical needs of the fast-growing pharmaceutical market.
    to achieve this goal, the company's experienced team has established strategic partnerships with the world's leading biopharmaceutical companies to create a broad product pipeline of innovative drugs.
    Reding Pharmaceuticals has established an in-house team with strong drug research and development and transformational research capabilities, and will build a pipeline of drug candidates with international intellectual property rights.
    our vision is to become a fully integrated and innovative biopharmaceutical company that develops, produces and sells innovative products to promote human health and well-being around the world.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.